Futura Medical Share Discussion Threads

[2 solaris] 12/3/2024 12:44

Will be delayed until after the election.

[petroc] 05/3/2024 19:57

MDI, are you there? I've got something to tell you.

[mdi] 03/3/2024 19:15

The LTR Pharma prospectus also mentions Petros Pharmaceuticals. It had higher revenue then Futura already from selling other class 2 medical devices for ED and Stendra which it is also looking to switch OTC. But its Market Cap is only a fraction of Futura Medical.

[broomrigg] 03/3/2024 18:27

MDI 26 Feb '15 - 08:41 - 46 of 13267........

"Yeah and the systemic side effects of Viagra are very mild!? Dry mouth, facial flushing etc. never mind the new cancer concerns associated with Viagra. And it's definitely a drug your doctor would not advise you take OTC and buy online. Just hope you don't get sent the ones with rat poison mixed into them from some back street factory. But if you are willing to use rubber bands to get an erection then I am sure a bit of blue rat poison won't hurt either? Maybe it will kill the STDs from also not using a condom!"

[mdi] 02/3/2024 12:45

Futura Medical market cap on paper currently being multiples of LTR referenced in the LTR prospectus and the product only being ‘an OTC medical device rather then a medication’

[takeiteasy] 02/3/2024 11:36

The
fifth
and
final
elephant
in
the
room

Is the point we have discussed here numerous times - just about every available treatment available has fundamental flaws for significant numbers of men. There is no "perfect" competition out there to worry about. Hence all the regulators are so keen to support us as a new entrant fully backed with scientific research.

(what not to do!)

I am done now with my thoughts here and will leave this thread alone until the results. I am gobsmacked with the behaviours of our bashers recently and am not here to have some form of courtroom debate if that is what they are gagging for....

The Global ED Market is expected to generate revenue of USD $7.10 BN by the end of 2026 so say recent research...so much to fight for :)

no advice intended with any of these posts - just thoughts to spark a sensible conversation etc :)

[broomrigg] 02/3/2024 10:58

I might have more success at getting through to ADVFN as I am a paid-up member.....mind you petroc, you have been very successful in the past at this.

[broomrigg] 02/3/2024 10:49

Hi petroc, I've posted on the ADVFN PROBLEMS board as you suggested......

Hello ADVFN, please could you take action on the posts above from petroc regarding the user MDI who has already been removed by yourselves multiple times in the past for breaking ADVFN policy. They use multiple IDs to bash Futura Medical (FUM) which is clearly against your rules. They cut and paste huge amounts of repetitive, outdated and irrelevent information with the sole aim of disrupting sensible, balanced discussion. Please could you remove this multi-ID nuisansce as they are ruining the debate.

Many thanks.

[mdi] 02/3/2024 09:57

A company called LTR Pharma recently IPO in Australia. Its behind Spontan. A nasal spray technology to treat ED. Works in less then 10 minutes, lower dosing and less side effects

Its market cap is only the equivalent of about £10m compared to Futura’s £120m

[takeiteasy] 02/3/2024 07:39

The
third
elephant
in
the
room

I got from our local Boots manager, who made it clear clients come in quietly grab a packet and walk out - they do not want ED advice(or anyone over hearing that they have issues in that department), they rely on the product and it becomes a repeat purchase as they rely on it.

Can you imagine any other social media outlet having people spend their lives trying to bash paracetamol or deep heat - of course not. And so as this product cycle moves from innovation to mainstream acceptance all the other arguments simply wash away...

dyor etc

[takeiteasy] 02/3/2024 07:31

Petroc, I am not in the least interested in what some serial misinformer/stock basher has to say hence leaving that thread. But if you are saying that every time I post I am somehow being responded to. Wow, that is basically a form of online stalking for goodness sakes - is any protection for that under the law.

To ensure everyone gets the message over these wretched Amazon scamming reviews - guess what actual percentage of the reviews are 1 star of the products sold.

Based on my assessment of February 2024 review data, and assuming only 4,000 sales which is likely to be an under estimate - so absolute tops < 0.8% of buyers rated this very poorly.

Much better to trust the firm's feedback on this basis...

MD interview - "Yes, we've had very few complaints. Out of the 200,000 packs that have been sold, we've received fewer than 100 complaints. Most of these are related to efficacy, which is understandable given that the product works in about 65% of men. Overall, the product has been well-received". 0.05% complaints rate is much lower than the Amazon rate, but both rates are still very low given this is a brand new innovation and will only work in certain men....

still like the chart pattern developing here...

dyor and no advice intended

[amt] 02/3/2024 06:47

Blimey MDI anyone would think you don't see any upside here. No need to keep banging on about it though.

[glavey] 02/3/2024 06:25

Erexon: 330 out of 423 (78%) reviewers recommend this product

Eroxon: 337 out of 451 (75%) reviewers don't recommend this product

[takeiteasy] 01/3/2024 22:41

The
second
elephant
in
the
room

The efficacy of Eroxon has been demonstrated in two Phase 3 trials in 300 men with mild, moderate, and severe ED.

It can work for everyone (subject to all my comments about having a capadity to produce nitrous oxide) and is a much wider audience than viagra as you do not need to exclude a majority of ED sufferers whose impaired health prevents them using blue pills.

Beyond all this, there is little more to say.

I realised long ago that our basher is mad with frustration that we have a superior product, broader market opportunity, world class marketing support globally ...the list goes on.

I made a prediction that the further the price shoots up over 40p the degree of frenzy in the postings will shoot up and we are seeing the evidence for that today...so pleased that he is now offline from this thread and long may that remain that way...

[mdi] 01/3/2024 20:23

Here is another EU approved Medical device. ‘Clinically proven’ and the study published in a leading scientific journal to have ‘more than 85% success rate’.



That efficacy ‘success rate’ is even higher then the placebo Eroxon can claim from FM57. Vertica also works out cheaper per use. 200 applications of Eroxon would cost over £1,200-00.



The results of our first clinical study, showing more than 85% success rate, have recently been published in a leading scientific journal, the IJIR – International Journal of Impotence Research, a member of the Nature group of publications. Now we have the scientific proof to support what our customers have been saying.”

[mdi] 01/3/2024 14:39

Others have posted regarding misleading rulings on similar class 2 medical device pain gels. FM57 was designed to study Med2005. It was not set up to study the placebo Med3000. So the results of FM57 which appear to show ‘surprising efficacy’ of the placebo are according to those same rules are just a ‘post hoc’ finding. FM57 or FM71 is still not proof of any effect beyond a similar placebo gel in any direct placebo gel blind study. All proven and posted by others.



Just like Flexiseq. Med3000 was also just the placebo in the FM57 study.Therefore like with Flexiseq. Futura had initially believed Med3000 had no therapeutic effect. The FM57 study did not set out to measure the efficacy of Med3000. The ASA will therefore consider that its reported effectiveness by Futura was a ‘post-hoc finding’

The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence

a certified Class IIb medical device. We understood that the device certification was granted by a body within the European Member States that had been designated to carry out conformity assessments under the Medical Device Directive

had been used as the placebo treatment in that study, and therefore the researcher had initially believed it had no therapeutic effect. The trial did not set out to measure the efficacy

its reported effectiveness by the advertiser was a post-hoc finding due to the risk of that being a false positive finding

We were also concerned that there was not an adequate placebo control in the trial. We, therefore, considered that the study did not provide adequate evidence for the claim ‘clinically proven’

[takeiteasy] 01/3/2024 14:30

The
elephant
in
the
room

Eroxon, was the “placebo”; used in FM57 and gave surprising results having efficacy approximately double that normally achieved in ED studies with regular placebos.

So 99% of social influencers appear to ignore this fact altogether that makes their argument look frankly daft and the 1% that do acknowledge this fact try to claim it has not really happened as they do not like the test design despite it being double blind.

This is like you are speeding along the motorway at 80mph and get stopped and try to explain to the officer that you were not speeding as all speedos overstate by 10% anyway and he explains that his radar gun is accurate to +/- 0.1%.

That is why we have the best global resellers with decades of experience fully on board with our data - the other vital fact that the social influencers (in the old days tried to press) - now they see the likes of Haleon on board they are less willing to look silly :)


dyor and no advice